New Zealand's PHARMAC Widens Access To Atorvastatin By Awarding Sole Supply Status For Generic
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Mylan's Lorstat (atorvastatin) will become New Zealand's only subsidized atorvastatin generic beginning Dec. 1. In addition, the Special Authority, which requires doctors to call in to receive authority to prescribe the drug, will be removed, reducing paperwork for prescribers and widening access to the drug